Cargando…
Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
SIMPLE SUMMARY: Glioblastoma (GB) is the most common and most deadly form of brain tumor in adults which currently lacks effective treatments. Thus, there is a high need to identify new and effective ways to target the aggressive GB cells and treat the GB patients. In this study, we investigated the...
Autores principales: | Masoumi, Katarzyna Chmielarska, Huang, Xiaoli, Sime, Wondossen, Mirkov, Anna, Munksgaard Thorén, Matilda, Massoumi, Ramin, Lundgren-Åkerlund, Evy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980568/ https://www.ncbi.nlm.nih.gov/pubmed/33803359 http://dx.doi.org/10.3390/cancers13051184 |
Ejemplares similares
-
Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
por: Munksgaard Thorén, Matilda, et al.
Publicado: (2019) -
NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2017) -
CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016) -
BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma
por: Sime, Wondossen, et al.
Publicado: (2018) -
Integrin α2β1 Is a Receptor for the Cartilage Matrix Protein Chondroadherin
por: Camper, Lisbet, et al.
Publicado: (1997)